The costs of treating vaginal and vulval cancer in England (2009–2015)
Abstract Background Human papillomavirus (HPV) infection is a pre-requisite for cervical cancer, which represents the third most common cancer among women worldwide. A causal relationship also exists between HPV and cancer in other areas of the female reproductive system including the vagina and vul...
Main Authors: | Stephanie Stephens, Anuja Chatterjee, Victoria Coles, Robin Crawford |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12889-020-08545-4 |
Similar Items
-
Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival
by: David Roder, et al.
Published: (2018-08-01) -
Living with vulval lichen sclerosus: Unheard stories and silenced voices
by: Sophie Rees
Published: (2021-01-01) -
Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
by: Pankaj Deka, et al.
Published: (2014-01-01) -
Recurrent vulval abscess caused by <em>Actinomyces</em> species: a case report
by: D. M. Casather
Published: (2021-04-01) -
Recurrent unilateral vulval elephantiasis: a case report.
by: Lakshmidevi Muralidhar, et al.
Published: (2014-06-01)